CCL2 and pancreatic neoplasm: In mouse melanoma and pancreatic cancer models, knockdown of CCL2 with siRNA or antibody neutralization effectively inhibited DC recruitment, reduced CD68+ macrophage infiltration, and decreased tumor growth and metastasis.118, 119, 120